若年性黄斑変性症(シュタルガルト病)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Juvenile Macular Degeneration (Stargardt Disease) Overview 6
Therapeutics Development 7
Pipeline Products for Juvenile Macular Degeneration (Stargardt Disease) – Overview 7
Pipeline Products for Juvenile Macular Degeneration (Stargardt Disease) – Comparative Analysis 8
Juvenile Macular Degeneration (Stargardt Disease) – Therapeutics under Development by Companies 9
Juvenile Macular Degeneration (Stargardt Disease) – Therapeutics under Investigation by Universities/Institutes 10
Juvenile Macular Degeneration (Stargardt Disease) – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Juvenile Macular Degeneration (Stargardt Disease) – Products under Development by Companies 13
Juvenile Macular Degeneration (Stargardt Disease) – Products under Investigation by Universities/Institutes 14
Juvenile Macular Degeneration (Stargardt Disease) – Companies Involved in Therapeutics Development 15
Acucela Inc. 15
Alkeus Pharmaceuticals, Inc. 16
Ocata Therapeutics, Inc. 17
Sanofi 18
Juvenile Macular Degeneration (Stargardt Disease) – Therapeutics Assessment 19
Assessment by Monotherapy Products 19
Assessment by Target 20
Assessment by Mechanism of Action 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
ALK-001 – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
echothiophate iodide – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
emixustat hydrochloride – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
Gene Therapy for Stargardt Disease – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
MA09-hRPE – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Small Molecule for Stargardt Disease – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
StarGen – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
VSM-20R – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Juvenile Macular Degeneration (Stargardt Disease) – Recent Pipeline Updates 40
Juvenile Macular Degeneration (Stargardt Disease) – Product Development Milestones 51
Featured News & Press Releases 51
Oct 15, 2014: ACT Announces Positive Results from Two Clinical Trials Published in The Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells for the Treatment of Macular Degeneration 51
Sep 25, 2014: Advanced Cell Technology Announces Final Patient Treated in Stargardt’s Macular Degeneration Phase 1 Trial in the United Kingdom 52
Jul 17, 2013: ACT Secures Approval from Data Safety Monitoring Board to Complete Third Patient Cohort in All Three Clinical Trials 52
May 16, 2013: ACT Confirms Clinical Trial Participant Shows Improvement In Vision Following Treatment With Human Embryonic Stem Cells 53
Apr 23, 2013: ACT Initiates Higher-Dosage Patient Treatment In European Phase I Study For Macular Degeneration 53
Apr 15, 2013: ACT Treats First Patient With Better Vision In Clinical Trial For Stargardt’s Macular Dystrophy 54
Apr 01, 2013: ACT Initiates Treatment Of Higher-dosage Cohort In Clinical Trials For Dry Age-related Macular Degeneration And Stargardt’s Macular Dystrophy 54
Mar 14, 2013: Advanced Cell Technology Receives DSMB Approval To Initiate Treatment Of Third Patient Cohort In All Three Clinical Trials Using hESC-derived RPE Cells 55
Jan 08, 2013: Advanced Cell Technology Achieves Clinical Milestone 56
Dec 17, 2012: ACT Completes Higher-Dosage Cohort In European Clinical Trial For Stargardt’s Macular Dystrophy Using Retinal Pigment Epithelial Cells 57
Appendix 58
Methodology 58
Coverage 58
Secondary Research 58
Primary Research 58
Expert Panel Validation 58
Contact Us 59
Disclaimer 59


【レポート販売概要】

■ タイトル:若年性黄斑変性症(シュタルガルト病)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6089IDB
■ 調査対象地域:グローバル
  • UAEの石油・ガス産業における中流(Midstream)市場展望
    United Arab Emirates Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "United Arab Emirates Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Unite …
  • ドイツの呼吸装置市場
    Germany Respiratory Devices Market Outlook to 2021 Summary GlobalData’s new report, "Germany Respiratory Devices Market Outlook to 2021", provides key market data on the Germany Respiratory Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Humidifiers, Oxygen Concentrators, Ventilators, Nebulizer …
  • コンクリート接着剤の世界市場
    ABSTRACTAbout Concrete Bonding Agents Concrete is a composite material, which is a mixture of coarse aggregates bonded together with a fluid cement that hardens over time. Bonding agents are used to enhance the joining of individual components of a structure without using mechanical fasteners. These products are used in repair applications such as bonding of fresh concrete, sprayed concrete, cemen …
  • アンチマネーロンダリング(AML)ソリューションの世界市場予測(~2024年)
    The exponential rise in money laundering and terrorist financing activities in the BFSI sector and increased adoption of digital payment modes to drive the overall AML solution marketThe global Anti-Money Laundering (AML) solution market size is projected to grow from USD 1.5 billion in 2019 to USD 3.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 19.5% during the forecast period. Va …
  • グローバルにおける動物用医療・製薬市場
    This new report from Venture Planning Group provides global animal health market outlook and leading suppliers' strategies, marketing tactics, and technological know-how. The report presents a worldwide strategic overview of the animal health market, including: Five-year forecasts for:                   - Major ma …
  • 潰瘍性大腸炎:グローバル医薬品市場動向(~2022)
    PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012–2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key …
  • グローバルにおける自動車ヘッドアップディスプレイ(HUD)市場(2014-2018)
    About Automotive Heads-up Display A head-up display is a device which projects a virtual image of instrumentation on the windscreen of a car which means that drivers do not need to adjust their usual viewpoint. The image detail is taken from an image source and then the image is generated in the HUD computer. The image is reflected through a relay lens assemble and is displayed on the collimator o …
  • Mucopolysaccharidosis VI (MPS VI) (マロト‐ラミー症候群):グローバル臨床試験動向(2014年上半期)
    Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) Global Clinical Trials Review, H1, 2014" provides data on the Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome) clinical trial scenario. This report provides elemental information and d …
  • マネージド・モビリティ・サービスの世界市場:モバイルサービス管理、セキュリティ及びコンテンツ管理、モバイルデバイス管理など
    The escalating penetration of mobile devices among businesses and the varying customer demands have enlarged the prospect of mobility solutions across diverse industry verticals to gain competitive advantage. From the usage of the mobile devices for professional work organizations are leveraging mobility for employee collaboration along with serving customers in a better manner by accessing organi …
  • 2014年市場分析:イタリアの肝炎診断
    Complete report $3,900.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report presents a detailed analysis of the Hepatitis diagnostics market in Italy.  Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.  The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-H …
  • 高性能断熱材の世界市場:エアロゲル、セラミック繊維、グラスバブル、EPS、XPS
    The high-performance insulation materials market is projected to reach USD 10.93 Billion by 2021, registering a CAGR of 11.2% between 2016 and 2021. The market is driven by the increased demand form the end-use applications such as oil & gas, industrial, construction, transportation, and paints & coatings, among others. Asia-Pacific region, with its growing economy and rapidly expanding commercial …
  • 世界のフォトマスク市場2015
    The Global Photomask Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Photomask industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Photomask market analysis is provided for the international markets including development trends, competitive landscap …
  • 世界の白血病治療市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Leukemia Therapeutics market to grow at a CAGR of 10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Leukemia Therapeutics market has also been witnessing an increase in the number of mergers and acquisitions. However, the delay in …
  • 世界のCRBN(化学・生物・放射性物質・核)防衛市場動向2013-2023:競合環境及び戦略的インサイト
    The report provides a detailed analysis of the competitive landscape of the CBRN market. It provides an overview of key CBRN companies catering to the CBRN sector, together with insights such as key alliances, strategic initiatives and a brief financial analysis. The global CBRN defense industry is highly competitive, with large numbers of suppliers catering to the requirements of countries around …
  • Dipropylene glycol dimethyl etherの世界市場
    Dipropylene glycol dimethyl ether (CAS 111109-77-4) Market Research Report 2013 presents comprehensive data on dipropylene glycol dimethyl ether markets globally and regionally (Europe, Asia, North America etc.) The Dipropylene glycol dimethyl ether (CAS 111109-77-4) Market Research Report 2013 includes dipropylene glycol dimethyl ether description, covers its application areas and related pattern …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。